Select Biotechnology PortfolioFBIOX
Type
Mutual fund
Peer group
US equity: Healthcare
Net assets
$5.4B
Expense ratio
0.62%
1-year return
+57.9%
3 years, a year
+26.3%
5 years, a year
+8.3%
Holdings
191
What it aims to do.
Biotechnology Portfolio seeks capital appreciation.
Top 10 holdings.
| Holding | % of fund |
|---|---|
| ABBV Abbvie Inc | 13.22% |
| KRYS Krystal Biotech Inc | 9.30% |
| GILD Gilead Sciences Inc | 8.77% |
| AMGN Amgen Inc | 8.34% |
| ALNY Alnylam Pharmaceuticals Inc | 3.09% |
| Fidelity Revere Street Trust | 2.55% |
| PRAX Praxis Precision Medicines Inc. | 2.46% |
| Ascendis Pharma A/S | 2.44% |
| INSM Insmed Inc | 2.26% |
| Ucb Sa | 2.17% |
More on FBIOX.
- FBIOX overview
- FBIOX holdings
- FBIOX risk
- FBIOX costs
- FBIOX money in and out
- FBIOX share classes
- Compare FBIOX with other funds
Returns after fees, from the fund's SEC filings up to Aug 2026. Past returns are not a promise. Not financial advice.